---
figid: PMC9061023__JO2022-2214686.005
pmcid: PMC9061023
image_filename: JO2022-2214686.005.jpg
figure_link: /pmc/articles/PMC9061023/figure/fig5/
number: Figure 5
figure_title: ''
caption: The value of PDGFD in immune therapy in gastric cancer. (a)â€“(h) After analyzing
  in TISIDB, PDGFD was significantly correlated with eight immune biomarkers in immunotherapy.
  (i) In TISIDB, PDGFD had the most highly expression in TGF-b dominant type of gastric
  cancer. (j) and (k) PDGFD was found to be the target of the type III receptor tyrosine
  kinases.
article_title: circ-0007707/miR-429/PDGFD Pathway Regulates the Progression of Gastric
  Cancer by Modulating the Immune-Gene Signature.
citation: Yang Yang, et al. J Oncol. 2022;2022:2214686.
year: '2022'

doi: 10.1155/2022/2214686
journal_title: Journal of Oncology
journal_nlm_ta: J Oncol
publisher_name: Hindawi

keywords:
---
